
Incircular
Incircular designs and stabilizes proteins using INCYPRO.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
€2.2m | Grant | ||
Total Funding | 000k |
Related Content
Incircular B.V. is a biotech startup based in Amsterdam, Netherlands, specializing in the design and stabilization of proteins using its proprietary technology called INCYPRO. This innovative and patented technology allows for the creation of robust proteins and enzymes, which are essential for various applications in the fields of therapeutics and diagnostics. The company primarily serves clients in the pharmaceutical and healthcare sectors, particularly those involved in drug development and diagnostic testing.
The market Incircular operates in is the biotechnology sector, with a specific focus on protein engineering. Protein instability is a common challenge in drug development and diagnostic applications, and Incircular addresses this issue by providing customized solutions that enhance protein stability. This makes their offerings highly valuable to research scientists and technicians working on developing new therapies and diagnostic tools.
Incircular's business model revolves around offering tailored protein engineering services to its clients. By leveraging the INCYPRO technology, the company can design proteins that meet specific stability requirements, thereby improving the efficacy and reliability of therapeutic and diagnostic products. The company generates revenue through service contracts with pharmaceutical companies, research institutions, and diagnostic firms that require stable proteins for their projects.
In summary, Incircular B.V. is a cutting-edge biotech company that provides essential protein stabilization solutions to the pharmaceutical and healthcare industries, helping to advance drug development and diagnostic technologies.
Keywords: biotech, protein engineering, INCYPRO, therapeutics, diagnostics, drug development, enzyme stabilization, healthcare, pharmaceutical, Amsterdam.